Biopharma stocks expected to climb higher after Democratic 'blue wave,' analysts say
Historical midterm patterns and Democrats' competing priorities are seen as limiting near-term drug pricing action.
Read at Biopharmadive โFull coverage ยท 6 outlets
- Biopharmadive ยท lead
- BioPharma DiveBiopharma likely to climb higher after โblue wave,โ analysts say
- ReutersSectors bracing for a pivot as US midterm elections loom
- Seeking AlphaWhat A Democratic Sweep Really Means For Stocks (NASDAQ:QQQ)
- Barron'sMidterm Elections: What a Blue Wave Would Mean for AI, Healthcare, and Other Industries
- BiopharmadiveBiopharma likely to climb higher after โblue wave,โ analysts say